Najarian: 'Fishy' options trade ahead of Puma news By: CNBC.com News July 23, 2014 at 10:56 AM EDT Someone bet big in the options market that Puma Biotechnology would be a winner in the days before a positive drug trial sent its stock soaring. Read More >> Related Stocks: Sentinelone Inc Cl A